Glycogen synthase kinase-3 as a therapeutic target for cognitive dysfunction in neuropsychiatric disorders

Neuroscience

• Cognitive Disorder 100%
• Glycogen Synthase Kinase 3 100%
• Glycogen Synthase Kinase 3 Inhibitor 60%
• Brain Disease 20%
• Mental Disorder 20%
• Neurodegenerative Disorder 20%
• Synaptic Plasticity 20%
• Cognitive Function 20%
• Programmed Cell Death 20%
• Cell Proliferation 20%
• Neurogenesis 20%
• Cell Survival 20%
• Mood Disorder 20%
• Alzheimer's Disease 20%
• Nervous System Cell 20%
• Fragile X Syndrome 20%
• Neurotrauma 20%
• Traumatic Brain Injury 20%
• Protein Serine Threonine Kinase 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Cognitive Defect 100%
• Glycogen Synthase Kinase 3 100%
• Glycogen Synthase Kinase 3 Inhibitor 60%
• Inflammation 20%
• Preclinical Study 20%
• Alzheimer's Disease 20%
• Cellular Processes 20%
• Mood Disorder 20%
• Brain Disease 20%
• Traumatic Brain Injury 20%
• Fragile X Syndrome 20%
• Protein Serine Threonine Kinase 20%